FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1975279812> ?p ?o ?g. }

• W1975279812 endingPage "47" @default.
• W1975279812 startingPage "39" @default.
• W1975279812 abstract "Patients with primary focal segmental glomerulosclerosis (FSGS) who are resistant to standard therapy are at high risk for progressive chronic kidney disease. Prevention of renal fibrosis represents a promising strategy to slow or halt kidney function decline. This paper presents the results of a Phase I clinical trial of rosiglitazone, a thiazolidinedione, that exerts antifibrotic effects in animal models of FSGS. The primary goal was assessment of safety, tolerability, and pharmacokinetics (PK) of rosiglitazone.Eleven patients, including eight boys/men and three girls/women, with mean age 15 +/- 6 yr and estimated GFR 131 +/- 62 ml/min/1.73 m(2), received rosiglitazone, 3 mg/m(2)/d for 16 wk. PK was assessed twice, after the initial dose and after attaining steady state, in a General Clinical Research Center.There were no serious adverse events or cardiovascular complications. Rosiglitazone was well tolerated by all patients, as judged by the Treatment Satisfaction Questionnaire for Medication. The PK studies indicated that the area under the curve was decreased by 40 to 50% and oral clearance of rosiglitazone was increased by 250 to 300% in patients with resistant FSGS compared with healthy controls and patients with nonproteinuric stage 2 chronic kidney disease.Rosiglitazone therapy was safe and well tolerated. PK assessment of potential novel therapies for resistant FSGS is necessary to define appropriate dosing regimens. There is rationale to evaluate the efficacy of rosiglitazone as an antifibrotic agent for resistant FSGS in Phase II/III clinical trials." @default.
• W1975279812 created "2016-06-24" @default.
• W1975279812 creator A5001037908 @default.
• W1975279812 creator A5004550033 @default.
• W1975279812 creator A5020716782 @default.
• W1975279812 creator A5029482359 @default.
• W1975279812 creator A5031318134 @default.
• W1975279812 creator A5039201887 @default.
• W1975279812 creator A5041406339 @default.
• W1975279812 creator A5044494633 @default.
• W1975279812 creator A5045125159 @default.
• W1975279812 creator A5054993212 @default.
• W1975279812 creator A5059150390 @default.
• W1975279812 date "2009-01-01" @default.
• W1975279812 modified "2023-09-26" @default.
• W1975279812 title "Phase I Trial of Rosiglitazone in FSGS" @default.
• W1975279812 cites W1965924089 @default.
• W1975279812 cites W1968330079 @default.
• W1975279812 cites W1970733045 @default.
• W1975279812 cites W2001798762 @default.
• W1975279812 cites W2007437966 @default.
• W1975279812 cites W2037825447 @default.
• W1975279812 cites W2050094658 @default.
• W1975279812 cites W2066004325 @default.
• W1975279812 cites W2102666508 @default.
• W1975279812 cites W2107589145 @default.
• W1975279812 cites W2118851182 @default.
• W1975279812 cites W2120416054 @default.
• W1975279812 cites W2127125241 @default.
• W1975279812 cites W2127594213 @default.
• W1975279812 cites W2130479018 @default.
• W1975279812 cites W2132714283 @default.
• W1975279812 cites W2144317224 @default.
• W1975279812 cites W2160362502 @default.
• W1975279812 cites W2163768678 @default.
• W1975279812 cites W4249862680 @default.
• W1975279812 doi "https://doi.org/10.2215/cjn.02310508" @default.
• W1975279812 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2615712" @default.
• W1975279812 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19073787" @default.
• W1975279812 hasPublicationYear "2009" @default.
• W1975279812 type Work @default.
• W1975279812 sameAs 1975279812 @default.
• W1975279812 citedByCount "33" @default.
• W1975279812 countsByYear W19752798122012 @default.
• W1975279812 countsByYear W19752798122013 @default.
• W1975279812 countsByYear W19752798122014 @default.
• W1975279812 countsByYear W19752798122015 @default.
• W1975279812 countsByYear W19752798122016 @default.
• W1975279812 countsByYear W19752798122018 @default.
• W1975279812 countsByYear W19752798122019 @default.
• W1975279812 countsByYear W19752798122020 @default.
• W1975279812 countsByYear W19752798122022 @default.
• W1975279812 crossrefType "journal-article" @default.
• W1975279812 hasAuthorship W1975279812A5001037908 @default.
• W1975279812 hasAuthorship W1975279812A5004550033 @default.
• W1975279812 hasAuthorship W1975279812A5020716782 @default.
• W1975279812 hasAuthorship W1975279812A5029482359 @default.
• W1975279812 hasAuthorship W1975279812A5031318134 @default.
• W1975279812 hasAuthorship W1975279812A5039201887 @default.
• W1975279812 hasAuthorship W1975279812A5041406339 @default.
• W1975279812 hasAuthorship W1975279812A5044494633 @default.
• W1975279812 hasAuthorship W1975279812A5045125159 @default.
• W1975279812 hasAuthorship W1975279812A5054993212 @default.
• W1975279812 hasAuthorship W1975279812A5059150390 @default.
• W1975279812 hasBestOaLocation W19752798121 @default.
• W1975279812 hasConcept C126322002 @default.
• W1975279812 hasConcept C126894567 @default.
• W1975279812 hasConcept C159641895 @default.
• W1975279812 hasConcept C170493617 @default.
• W1975279812 hasConcept C197934379 @default.
• W1975279812 hasConcept C2777288759 @default.
• W1975279812 hasConcept C2778375690 @default.
• W1975279812 hasConcept C2778653478 @default.
• W1975279812 hasConcept C2780152017 @default.
• W1975279812 hasConcept C535046627 @default.
• W1975279812 hasConcept C71924100 @default.
• W1975279812 hasConceptScore W1975279812C126322002 @default.
• W1975279812 hasConceptScore W1975279812C126894567 @default.
• W1975279812 hasConceptScore W1975279812C159641895 @default.
• W1975279812 hasConceptScore W1975279812C170493617 @default.
• W1975279812 hasConceptScore W1975279812C197934379 @default.
• W1975279812 hasConceptScore W1975279812C2777288759 @default.
• W1975279812 hasConceptScore W1975279812C2778375690 @default.
• W1975279812 hasConceptScore W1975279812C2778653478 @default.
• W1975279812 hasConceptScore W1975279812C2780152017 @default.
• W1975279812 hasConceptScore W1975279812C535046627 @default.
• W1975279812 hasConceptScore W1975279812C71924100 @default.
• W1975279812 hasIssue "1" @default.
• W1975279812 hasLocation W19752798121 @default.
• W1975279812 hasLocation W19752798122 @default.
• W1975279812 hasLocation W19752798123 @default.
• W1975279812 hasLocation W19752798124 @default.
• W1975279812 hasOpenAccess W1975279812 @default.
• W1975279812 hasPrimaryLocation W19752798121 @default.
• W1975279812 hasRelatedWork W1989802976 @default.
• W1975279812 hasRelatedWork W1995894256 @default.
• W1975279812 hasRelatedWork W2055352031 @default.
• W1975279812 hasRelatedWork W2084265116 @default.

• next